Learning Hub Central

Pharmacological

← Back to Specialities

2025 SPS Puerto Rico | Infliximab Intravenous vs. Subcutaneous: Clinical and Practice Considerations

Pharmacological

1 Chapter

Non-CME Credit Course

2025 SPS Puerto Rico | An Expanding Bispecifics Armamentarium: Zanidatamab Clinical Review and Considerations

Pharmacological

1 Chapter

Non-CME Credit Course

2025 SPS Puerto Rico | Concomitant Antithrombotic Therapy (CAT): Less is More?

Pharmacological

1 Chapter

Non-CME Credit Course

2024 PACC Miami | Two for the Price of One: Review of Bispecific Antibodies in Lymphoma and Myeloma

Pharmacological

1 Chapter

Non-CME Credit Course

2024 PACC Miami | Novel IntraVesical Therapies | Transition from Clinical Operations to Operational Considerations

Pharmacological

1 Chapter

Non-CME Credit Course

$2024 PACC Miami | When the CARs Crash, What is Next? A Review of Relapsed / Refractory Treatment Options in DLBCL$

2024 PACC Miami | When the CARs Crash, What is Next? A Review of Relapsed / Refractory Treatment Options in DLBCL

Pharmacological

1 Chapter

Non-CME Credit Course

2024 PACC Miami | New Frontiers in Breast Oncology

Pharmacological

1 Chapter

Non-CME Credit Course

2024 PACC Miami | Clinical Review of Tarlatamab-dlle, The First Bispecific T-Cell Engager (BiTE) Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer

Pharmacological

1 Chapter

Non-CME Credit Course

2024 PACC Miami | Clinical and Practice Considerations in the Management of Iron Deficiency Anemia with IV Infusion

Pharmacological

1 Chapter

Non-CME Credit Course

2024 PACC Miami | Billing for Pharmacist Services in Oncology Setting

Pharmacological

1 Chapter

Non-CME Credit Course

$2024 PACC Miami | Advancement in Therapy Options for BCG-Refractory Patients$

2024 PACC Miami | Advancement in Therapy Options for BCG-Refractory Patients

Pharmacological

1 Chapter

Non-CME Credit Course

SPS Puerto Rico 2024 | Obesity Management with Incretin Therapies: Considerations for Patients with and without Type 2 Diabetes

Pharmacological

1 Chapter

Non-CME Credit Course

SPS Puerto Rico 2024 | Leveraging NCODA Resources to Manage Patients on Oral Oncolytics

Pharmacological

1 Chapter

Non-CME Credit Course

Malignant Hematology and Use of Bi-specifics in Puerto Rico

Pharmacological

1 Chapter

Non-CME Credit Course

SPS Puerto Rico 2024 | Diabetes Management in the Face of Healthcare Disparities

Pharmacological

1 Chapter

Non-CME Credit Course

SPS Puerto Rico 2024 | Neurology Drug Update

Pharmacological

1 Chapter

Non-CME Credit Course

SPS Puerto Rico 2024 | Role of Pharmacist in Vaccination: Challenges and Opportunities

Pharmacological

1 Chapter

Non-CME Credit Course

2024 NOSCM | Pharmacology I: What HemOnc Clinicians Must Know in Immunotherapy

Pharmacological

1 Chapter

Non-CME Credit Course

2024 SPS Seattle | Development of Pharmacy-Led Ambulatory Infusion Services (Part 3)

Pharmacological

1 Chapter

Non-CME Credit Course

2024 SPS Seattle | Development of Pharmacy-Led Ambulatory Infusion Services (Part 2)

Pharmacological

1 Chapter

Non-CME Credit Course

2024 SPS Seattle | Development of Pharmacy-Led Ambulatory Infusion Services (Part 1)

Pharmacological

1 Chapter

Non-CME Credit Course

2024 SPS Seattle | Patient Centered Pharmaceutical Care in Community Setting

Pharmacological

1 Chapter

Non-CME Credit Course

2024 SPS Seattle | White Bagging & The Movement for Policy Development

Pharmacological

1 Chapter

Non-CME Credit Course

2024 SPS Seattle | Clinical and Practice Considerations in the Management of Iron Deficiency Anemia

Pharmacological

1 Chapter

Non-CME Credit Course

SPS Puerto Rico 2024 | ASHP Pharmacy Forecast Update

Pharmacological

1 Chapter

Non-CME Credit Course

2024 PRIMO | Payor Benefits Design Changing Oncology Care Delivery

Pharmacological

1 Chapter

Non-CME Credit Course

The Role of the Antimicrobial Stewardship Pharmacist in the Care of the Oncology Patient

Pharmacological

1 Chapter

Non-CME Credit Course

From the Young to the Grown-up; Pharmacotherapy Updates in Acute Lymphoblastic Leukemia (ALL)

Pharmacological

1 Chapter

Non-CME Credit Course

2022 Pharmacotherapy Lecture Series | Pharmacologic Review of Cardiotoxic Chemotherapies

Pharmacological

1 Chapter

Non-CME Credit Course

2022 Pharmacotherapy Lecture Series | Antiemesis: A comparison of Treatment Approach between NCCN and ASCO Guidelines

Pharmacological

1 Chapter

Non-CME Credit Course

2022 Pharmacotherapy Lecture Series | Contemporary Pharmacotherapy Management of High-grade Gliomas

Pharmacological

1 Chapter

Non-CME Credit Course

2022 Pharmacotherapy Lecture Series | Pharmacotherapy Management in Chronic Lymphocytic Leukemia (CLL)

Pharmacological

1 Chapter

Non-CME Credit Course

Oncology Medication Safety; Building a Culture of Best Practices

Pharmacological

1 Chapter

Non-CME Credit Course

2024 PACC Miami | Empowering Research with Excelling and Expanding Pharmacy Services

Pharmacological

1 Chapter

Non-CME Credit Course

Everything You Wanted To Know About the Pitt-Cal U54 Pharmacokinetics Resource Laboratory

Pharmacological

1 Chapter

Non-CME Credit Course

2024 PACC Miami | Establishment of a Biosimilar Economic Dashboard to Inform Organizational Strategy

Pharmacological

1 Chapter

Non-CME Credit Course

2024 PACC Miami | Oncology Pharmacy Training; A Discussion with Kelley Carlstrom

Pharmacological

1 Chapter

Non-CME Credit Course

Contact Us

info@meccinc.com

(305) 663-1628